See more : China Resources Pharmaceutical Group Limited (3320.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Salona Global Medical Device Corporation (SGMD.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Salona Global Medical Device Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Playtech plc (PYTCF) Income Statement Analysis – Financial Results
- Walgreens Boots Alliance, Inc. (WBA) Income Statement Analysis – Financial Results
- Genex Pharmaceutical, Inc. (GENX) Income Statement Analysis – Financial Results
- Augwind Energy Tech Storage Ltd (ITGMF) Income Statement Analysis – Financial Results
- Rossari Biotech Limited (ROSSARI.BO) Income Statement Analysis – Financial Results
Salona Global Medical Device Corporation (SGMD.V)
About Salona Global Medical Device Corporation
Salona Global Medical Device Corporation, through its subsidiaries, engages in the production and sale of medical devices and products in the United States. The company's medical devices are used for pain management, cold and hot therapy, transcutaneous electronic nerve and neuromuscular electrical stimulation, pulsed electromagnetic field technology, and ultrasound therapy. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Brattle Street Investment Corp. and changed its name to Salona Global Medical Device Corporation in December 2020. Salona Global Medical Device Corporation was incorporated in 2013 and is headquartered in Del Mar, California.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.31M | -33.55K | 352.13K | 3.15M | 3.94M | 3.94M | 2.10M | 359.01K |
| Cost of Revenue | 12.35M | 12.35M | 372.46K | 61.85K | 6.77M | 825.30K | 945.80K | 21.37K |
| Gross Profit | 5.96M | -12.38M | -20.33K | 3.09M | -2.83M | 3.12M | 1.16M | 337.64K |
| Gross Profit Ratio | 32.56% | 36,914.62% | -5.77% | 98.03% | -71.87% | 79.08% | 55.02% | 94.05% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.73M | 990.28K | 1.71M | 3.83M | 4.97M | 5.09M | 3.84M | 1.49M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 11.57K | 3.07K | 296.62K | 540.74K | 0.00 |
| SG&A | 5.73M | 990.28K | 1.71M | 3.85M | 4.97M | 5.39M | 4.38M | 1.49M |
| Other Expenses | -3.84M | -1.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.57M | 990.28K | 1.71M | 3.85M | 4.97M | 5.39M | 4.38M | 1.49M |
| Cost & Expenses | 18.92M | 990.28K | 2.08M | 3.91M | 11.74M | 6.21M | 5.33M | 1.51M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 388.07K | 388.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 841.77K | 841.77K | 54.52K | 256.04K | 276.73K | 83.19K | 1.27K | -460.62K |
| EBITDA | -3.61M | -1.02M | -1.63M | -504.53K | -7.41M | 4.22M | -3.28M | -1.38M |
| EBITDA Ratio | -19.71% | 3,051.93% | -464.06% | -16.03% | -188.01% | 106.97% | -156.23% | -385.19% |
| Operating Income | -4.45M | -1.02M | -1.69M | -760.57K | -7.68M | -8.67M | -3.17M | -922.25K |
| Operating Income Ratio | -24.30% | 3,051.93% | -479.55% | -24.17% | -195.04% | -219.77% | -150.58% | -256.89% |
| Total Other Income/Expenses | -3.87M | -1.64M | 337.97K | 0.00 | -241.61K | 33.09K | 0.00 | 0.00 |
| Income Before Tax | -4.47M | -2.67M | -1.77M | -760.57K | -7.92M | -8.64M | -3.17M | -922.25K |
| Income Before Tax Ratio | -24.43% | 7,951.30% | -502.04% | -24.17% | -201.17% | -218.93% | -150.58% | -256.89% |
| Income Tax Expense | -101.62K | -101.62K | 613.11K | 0.00 | 135.29K | 26.19K | -74.81K | 230.31K |
| Net Income | -4.37M | -2.67M | -2.34M | -760.57K | -8.06M | -8.66M | -3.09M | -922.25K |
| Net Income Ratio | -23.87% | 7,951.30% | -664.91% | -24.17% | -204.61% | -219.59% | -147.03% | -256.89% |
| EPS | -0.10 | -0.06 | -0.07 | -0.02 | -0.24 | -0.29 | -0.13 | -0.15 |
| EPS Diluted | -0.10 | -0.06 | -0.07 | -0.02 | -0.24 | -0.29 | -0.13 | -0.15 |
| Weighted Avg Shares Out | 43.63M | 43.63M | 33.79M | 33.79M | 33.79M | 29.66M | 24.57M | 6.12M |
| Weighted Avg Shares Out (Dil) | 43.63M | 43.63M | 33.79M | 33.79M | 33.79M | 29.66M | 24.57M | 6.12M |
Source: https://incomestatements.info
Category: Stock Reports